

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of integrin activation (GO:0033623) | 4.97808306 |
| 2 | macroautophagy (GO:0016236) | 4.37515154 |
| 3 | proline biosynthetic process (GO:0006561) | 4.35027980 |
| 4 | semaphorin-plexin signaling pathway (GO:0071526) | 4.19965604 |
| 5 | apoptotic cell clearance (GO:0043277) | 4.13183909 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.59622659 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.59622659 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 3.59622659 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 3.59622659 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 3.59622659 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.59622659 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.56313612 |
| 13 | positive regulation of protein homooligomerization (GO:0032464) | 3.35159238 |
| 14 | mannose metabolic process (GO:0006013) | 3.34012816 |
| 15 | positive regulation of p38MAPK cascade (GO:1900745) | 3.16785212 |
| 16 | cell-cell junction maintenance (GO:0045217) | 3.14659708 |
| 17 | endothelial cell chemotaxis (GO:0035767) | 3.14589507 |
| 18 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.14432881 |
| 19 | protein localization to endosome (GO:0036010) | 3.08593305 |
| 20 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.07582451 |
| 21 | proline metabolic process (GO:0006560) | 3.06214818 |
| 22 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.02112619 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.01020705 |
| 24 | positive regulation of receptor recycling (GO:0001921) | 3.00064176 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 2.94924789 |
| 26 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.91675505 |
| 27 | regulation of protein polyubiquitination (GO:1902914) | 2.88929766 |
| 28 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.87239347 |
| 29 | negative regulation of fatty acid transport (GO:2000192) | 2.85991561 |
| 30 | desmosome organization (GO:0002934) | 2.84734756 |
| 31 | negative regulation of cell size (GO:0045792) | 2.83264036 |
| 32 | regulation of protein homooligomerization (GO:0032462) | 2.80484446 |
| 33 | positive regulation of protein kinase C signaling (GO:0090037) | 2.80036550 |
| 34 | embryonic placenta development (GO:0001892) | 2.76323015 |
| 35 | synaptic vesicle endocytosis (GO:0048488) | 2.75991222 |
| 36 | regulation of ARF GTPase activity (GO:0032312) | 2.75641045 |
| 37 | negative regulation of granulocyte differentiation (GO:0030853) | 2.75196699 |
| 38 | phospholipid homeostasis (GO:0055091) | 2.74892820 |
| 39 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.71716119 |
| 40 | response to muramyl dipeptide (GO:0032495) | 2.71337208 |
| 41 | embryonic process involved in female pregnancy (GO:0060136) | 2.69674131 |
| 42 | barbed-end actin filament capping (GO:0051016) | 2.67994081 |
| 43 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.67621340 |
| 44 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.66481071 |
| 45 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.64483960 |
| 46 | hemidesmosome assembly (GO:0031581) | 2.63437825 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 2.62314185 |
| 48 | plasma membrane repair (GO:0001778) | 2.62138932 |
| 49 | cell adhesion mediated by integrin (GO:0033627) | 2.59917122 |
| 50 | regulation of early endosome to late endosome transport (GO:2000641) | 2.59706707 |
| 51 | response to peptidoglycan (GO:0032494) | 2.58733703 |
| 52 | cellular response to ATP (GO:0071318) | 2.57974482 |
| 53 | negative regulation of cell killing (GO:0031342) | 2.57570594 |
| 54 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.57570594 |
| 55 | regulation of cholesterol storage (GO:0010885) | 2.57390073 |
| 56 | regulation of p38MAPK cascade (GO:1900744) | 2.56079858 |
| 57 | germinal center formation (GO:0002467) | 2.54822290 |
| 58 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.54494150 |
| 59 | cell junction maintenance (GO:0034331) | 2.52594967 |
| 60 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.52247332 |
| 61 | receptor catabolic process (GO:0032801) | 2.52024765 |
| 62 | I-kappaB phosphorylation (GO:0007252) | 2.50464804 |
| 63 | activation of Rac GTPase activity (GO:0032863) | 2.50235006 |
| 64 | alanine transport (GO:0032328) | 2.48881273 |
| 65 | lysosome organization (GO:0007040) | 2.48339086 |
| 66 | lytic vacuole organization (GO:0080171) | 2.48339086 |
| 67 | cell volume homeostasis (GO:0006884) | 2.47849449 |
| 68 | regulation of ARF protein signal transduction (GO:0032012) | 2.47377410 |
| 69 | positive regulation of protein dephosphorylation (GO:0035307) | 2.47267165 |
| 70 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.46955784 |
| 71 | regulation of podosome assembly (GO:0071801) | 2.46669410 |
| 72 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.46062037 |
| 73 | cell-substrate junction assembly (GO:0007044) | 2.45501442 |
| 74 | adherens junction assembly (GO:0034333) | 2.44801631 |
| 75 | lipoprotein transport (GO:0042953) | 2.44302406 |
| 76 | positive regulation of Rac GTPase activity (GO:0032855) | 2.43901478 |
| 77 | positive regulation of nuclease activity (GO:0032075) | 2.42377182 |
| 78 | signal complex assembly (GO:0007172) | 2.42197664 |
| 79 | endocytic recycling (GO:0032456) | 2.41673840 |
| 80 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.40675029 |
| 81 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.39888809 |
| 82 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.39682741 |
| 83 | apoptotic process involved in morphogenesis (GO:0060561) | 2.39556704 |
| 84 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.38937638 |
| 85 | response to manganese ion (GO:0010042) | 2.38839597 |
| 86 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.38481765 |
| 87 | regulation of water loss via skin (GO:0033561) | 2.38283482 |
| 88 | positive regulation of protein deacetylation (GO:0090312) | 2.37847492 |
| 89 | protein retention in ER lumen (GO:0006621) | 2.37626284 |
| 90 | establishment of apical/basal cell polarity (GO:0035089) | 2.37378398 |
| 91 | cell-substrate adherens junction assembly (GO:0007045) | 2.36625140 |
| 92 | focal adhesion assembly (GO:0048041) | 2.36625140 |
| 93 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.36516102 |
| 94 | positive regulation of leukocyte degranulation (GO:0043302) | 2.35586290 |
| 95 | positive regulation of protein oligomerization (GO:0032461) | 2.33158927 |
| 96 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.32466679 |
| 97 | epithelial cell-cell adhesion (GO:0090136) | 2.31859292 |
| 98 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.31092138 |
| 99 | response to host immune response (GO:0052572) | 2.31092138 |
| 100 | positive regulation of cholesterol efflux (GO:0010875) | 2.29725583 |
| 101 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.29118653 |
| 102 | positive regulation of histone deacetylation (GO:0031065) | 2.27052096 |
| 103 | response to laminar fluid shear stress (GO:0034616) | 2.26573336 |
| 104 | negative regulation of interleukin-8 production (GO:0032717) | 2.25645407 |
| 105 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.23720979 |
| 106 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.23337085 |
| 107 | negative regulation of viral release from host cell (GO:1902187) | 2.23236672 |
| 108 | regulation of translational fidelity (GO:0006450) | 2.21868417 |
| 109 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.21573052 |
| 110 | adenosine receptor signaling pathway (GO:0001973) | 2.20783392 |
| 111 | response to fluid shear stress (GO:0034405) | 2.20716475 |
| 112 | activation of MAPKKK activity (GO:0000185) | 2.20492217 |
| 113 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.19672312 |
| 114 | NIK/NF-kappaB signaling (GO:0038061) | 2.19657390 |
| 115 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.19600372 |
| 116 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.19338283 |
| 117 | thymic T cell selection (GO:0045061) | 2.18184831 |
| 118 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.17178281 |
| 119 | cellular response to unfolded protein (GO:0034620) | 2.16998227 |
| 120 | stress fiber assembly (GO:0043149) | 2.16995124 |
| 121 | regulation of regulated secretory pathway (GO:1903305) | 2.16587528 |
| 122 | regulation of extracellular matrix disassembly (GO:0010715) | 2.16312668 |
| 123 | Rho protein signal transduction (GO:0007266) | 2.16227837 |
| 124 | cellular response to fluid shear stress (GO:0071498) | 2.16108447 |
| 125 | regulation of nuclease activity (GO:0032069) | 2.15802604 |
| 126 | activation of JUN kinase activity (GO:0007257) | 2.15378342 |
| 127 | regulation of mast cell degranulation (GO:0043304) | 2.14899321 |
| 128 | positive thymic T cell selection (GO:0045059) | 2.14043642 |
| 129 | actin filament bundle assembly (GO:0051017) | 2.13767422 |
| 130 | actin filament bundle organization (GO:0061572) | 2.13767422 |
| 131 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.13598677 |
| 132 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.13102056 |
| 133 | regulation of leukocyte degranulation (GO:0043300) | 2.13090848 |
| 134 | low-density lipoprotein particle clearance (GO:0034383) | 2.12881344 |
| 135 | positive regulation of Rap GTPase activity (GO:0032854) | 2.12574383 |
| 136 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.12081149 |
| 137 | response to host (GO:0075136) | 2.12081149 |
| 138 | response to host defenses (GO:0052200) | 2.12081149 |
| 139 | negative regulation of stress fiber assembly (GO:0051497) | 2.11750861 |
| 140 | neutrophil mediated immunity (GO:0002446) | 2.11714305 |
| 141 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.11569410 |
| 142 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.10583597 |
| 143 | regulation of bone resorption (GO:0045124) | 2.10469404 |
| 144 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.10425656 |
| 145 | negative regulation of myotube differentiation (GO:0010832) | 2.10283101 |
| 146 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.10084645 |
| 147 | negative regulation of macroautophagy (GO:0016242) | 2.09831066 |
| 148 | positive regulation of Rho GTPase activity (GO:0032321) | 2.09646978 |
| 149 | regulation of protein oligomerization (GO:0032459) | 2.09510877 |
| 150 | retrograde transport, endosome to Golgi (GO:0042147) | 2.09475939 |
| 151 | GDP-mannose metabolic process (GO:0019673) | 2.09223672 |
| 152 | atrioventricular valve morphogenesis (GO:0003181) | 2.08271679 |
| 153 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.07276999 |
| 154 | modulation by symbiont of host cellular process (GO:0044068) | 2.06758294 |
| 155 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.06278120 |
| 156 | regulation of response to reactive oxygen species (GO:1901031) | 2.05950793 |
| 157 | negative regulation of interleukin-12 production (GO:0032695) | 2.05898904 |
| 158 | negative regulation of Ras GTPase activity (GO:0034261) | 2.05751689 |
| 159 | sodium ion export (GO:0071436) | 2.05723978 |
| 160 | ER-nucleus signaling pathway (GO:0006984) | 2.05031445 |
| 161 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.04771840 |
| 162 | detection of molecule of bacterial origin (GO:0032490) | 2.04585713 |
| 163 | establishment of skin barrier (GO:0061436) | 2.03985449 |
| 164 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.03524147 |
| 165 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.03473880 |
| 166 | N-acetylneuraminate metabolic process (GO:0006054) | 2.01770023 |
| 167 | cellular response to virus (GO:0098586) | 2.00950403 |
| 168 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.00829989 |
| 169 | regulation of ruffle assembly (GO:1900027) | 2.00455303 |
| 170 | histone H4 deacetylation (GO:0070933) | 1.98076127 |
| 171 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.97181023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.61384813 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.58233783 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.26649105 |
| 4 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.25751157 |
| 5 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.23631763 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.20913148 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.15192281 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97193638 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.96356736 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94004621 |
| 11 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.90198888 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84336073 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.83293357 |
| 14 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.81618871 |
| 15 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.77053001 |
| 16 | KDM2B_26808549_Chip-Seq_K562_Human | 1.76486685 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.74692851 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73729900 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71285651 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70897753 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68019788 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64981017 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64267595 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63202377 |
| 25 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61714322 |
| 26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.61235913 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61203879 |
| 28 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59806316 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58205636 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53865866 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51682500 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.47579108 |
| 33 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.47362916 |
| 34 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.46745011 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.46452995 |
| 36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43888176 |
| 37 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.43082160 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42670786 |
| 39 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42478968 |
| 40 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40323529 |
| 41 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39522996 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39043066 |
| 43 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.38716575 |
| 44 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.38578267 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37854363 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.37255577 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36674187 |
| 48 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35940051 |
| 49 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35564715 |
| 50 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.34937056 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32136236 |
| 52 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31785638 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.31520859 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30054304 |
| 55 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.29728805 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.29492174 |
| 57 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.29104733 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28543866 |
| 59 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.28329053 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27801343 |
| 61 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.27452019 |
| 62 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.27372641 |
| 63 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25650213 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24953649 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22944609 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22616636 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22343809 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22330293 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21667838 |
| 70 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20251110 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19479022 |
| 72 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19084474 |
| 73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.19005884 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.17901358 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17892046 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17705647 |
| 77 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16265079 |
| 78 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15865621 |
| 79 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15719850 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15188030 |
| 81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14194524 |
| 82 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12189310 |
| 83 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10963882 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10248412 |
| 85 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09443107 |
| 86 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.09125334 |
| 87 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07714391 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07649074 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07611200 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07046758 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07034606 |
| 92 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06865238 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06842881 |
| 94 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05661253 |
| 95 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05196751 |
| 96 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.04253279 |
| 97 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04230980 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.03417028 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.03417028 |
| 100 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.02907845 |
| 101 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01886367 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01815428 |
| 103 | MYC_22102868_ChIP-Seq_BL_Human | 1.00825534 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99962180 |
| 105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98902302 |
| 106 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98394902 |
| 107 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98292612 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97982810 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97743921 |
| 110 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97657067 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96514200 |
| 112 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96114511 |
| 113 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.95896743 |
| 114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94765923 |
| 115 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.94745071 |
| 116 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94621571 |
| 117 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94551609 |
| 118 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.94312147 |
| 119 | MAF_26560356_Chip-Seq_TH1_Human | 0.93791495 |
| 120 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93098356 |
| 121 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.92323425 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91471619 |
| 123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91259794 |
| 124 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.91051843 |
| 125 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90906706 |
| 126 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90556248 |
| 127 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90067161 |
| 128 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88310785 |
| 129 | P68_20966046_ChIP-Seq_HELA_Human | 0.87446565 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87196103 |
| 131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87064635 |
| 132 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.86641949 |
| 133 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86064461 |
| 134 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85890910 |
| 135 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84466658 |
| 136 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84434204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.72315479 |
| 2 | MP0003172_abnormal_lysosome_physiology | 5.48434705 |
| 3 | MP0005058_abnormal_lysosome_morphology | 5.08076700 |
| 4 | MP0009278_abnormal_bone_marrow | 3.65529669 |
| 5 | MP0005409_darkened_coat_color | 2.86035403 |
| 6 | MP0005174_abnormal_tail_pigmentation | 2.75822926 |
| 7 | MP0003283_abnormal_digestive_organ | 2.70995216 |
| 8 | MP0003045_fibrosis | 2.57255008 |
| 9 | MP0000371_diluted_coat_color | 2.29052370 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.28930209 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.26310258 |
| 12 | MP0004510_myositis | 2.25695022 |
| 13 | MP0005076_abnormal_cell_differentiation | 2.23069516 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 2.19628026 |
| 15 | MP0005451_abnormal_body_composition | 2.11536416 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.11043004 |
| 17 | MP0004233_abnormal_muscle_weight | 2.10825137 |
| 18 | MP0004381_abnormal_hair_follicle | 2.10491033 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.06492345 |
| 20 | MP0000015_abnormal_ear_pigmentation | 2.03045966 |
| 21 | MP0009840_abnormal_foam_cell | 1.93717981 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.86913776 |
| 23 | MP0008260_abnormal_autophagy | 1.85785252 |
| 24 | MP0005257_abnormal_intraocular_pressure | 1.70198493 |
| 25 | MP0008961_abnormal_basal_metabolism | 1.70070018 |
| 26 | MP0003879_abnormal_hair_cell | 1.64220952 |
| 27 | MP0002796_impaired_skin_barrier | 1.63132516 |
| 28 | MP0005670_abnormal_white_adipose | 1.62330876 |
| 29 | MP0001348_abnormal_lacrimal_gland | 1.50934914 |
| 30 | MP0010307_abnormal_tumor_latency | 1.50134578 |
| 31 | MP0001958_emphysema | 1.45655063 |
| 32 | MP0004264_abnormal_extraembryonic_tissu | 1.44633668 |
| 33 | MP0003329_amyloid_beta_deposits | 1.43282234 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.42563349 |
| 35 | MP0006082_CNS_inflammation | 1.41924361 |
| 36 | MP0005083_abnormal_biliary_tract | 1.41467493 |
| 37 | MP0002933_joint_inflammation | 1.40544145 |
| 38 | MP0003303_peritoneal_inflammation | 1.40190316 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.36756380 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.30745697 |
| 41 | MP0005025_abnormal_response_to | 1.29919906 |
| 42 | MP0004859_abnormal_synaptic_plasticity | 1.29102833 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.26098893 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.26098893 |
| 45 | MP0004130_abnormal_muscle_cell | 1.25858660 |
| 46 | MP0004858_abnormal_nervous_system | 1.22352918 |
| 47 | MP0002168_other_aberrant_phenotype | 1.21189618 |
| 48 | MP0003075_altered_response_to | 1.19306149 |
| 49 | MP0003091_abnormal_cell_migration | 1.19160326 |
| 50 | MP0005365_abnormal_bile_salt | 1.16335846 |
| 51 | MP0003436_decreased_susceptibility_to | 1.16118685 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.15340776 |
| 53 | MP0008438_abnormal_cutaneous_collagen | 1.15175398 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.14510026 |
| 55 | MP0000751_myopathy | 1.11812892 |
| 56 | MP0005171_absent_coat_pigmentation | 1.11240481 |
| 57 | MP0005377_hearing/vestibular/ear_phenot | 1.09616362 |
| 58 | MP0003878_abnormal_ear_physiology | 1.09616362 |
| 59 | MP0000604_amyloidosis | 1.09255344 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.08979621 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.08868321 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.08474694 |
| 63 | MP0002269_muscular_atrophy | 1.07854006 |
| 64 | MP0002928_abnormal_bile_duct | 1.04981864 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.03307011 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.01328877 |
| 67 | MP0000858_altered_metastatic_potential | 1.00696964 |
| 68 | MP0001324_abnormal_eye_pigmentation | 1.00052146 |
| 69 | MP0004947_skin_inflammation | 0.98914788 |
| 70 | MP0002419_abnormal_innate_immunity | 0.98527151 |
| 71 | MP0003690_abnormal_glial_cell | 0.97896606 |
| 72 | MP0009780_abnormal_chondrocyte_physiolo | 0.96440892 |
| 73 | MP0005501_abnormal_skin_physiology | 0.94958174 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 0.94877425 |
| 75 | MP0002452_abnormal_antigen_presenting | 0.93952809 |
| 76 | MP0008874_decreased_physiological_sensi | 0.93812896 |
| 77 | MP0002909_abnormal_adrenal_gland | 0.93675087 |
| 78 | MP0001216_abnormal_epidermal_layer | 0.92764182 |
| 79 | MP0009046_muscle_twitch | 0.92176514 |
| 80 | MP0002089_abnormal_postnatal_growth/wei | 0.91529054 |
| 81 | MP0008004_abnormal_stomach_pH | 0.91160588 |
| 82 | MP0001800_abnormal_humoral_immune | 0.91152913 |
| 83 | MP0001765_abnormal_ion_homeostasis | 0.90470782 |
| 84 | MP0002723_abnormal_immune_serum | 0.90153154 |
| 85 | MP0005423_abnormal_somatic_nervous | 0.89833202 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.89529352 |
| 87 | MP0005023_abnormal_wound_healing | 0.89461064 |
| 88 | MP0009931_abnormal_skin_appearance | 0.88898324 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.88522633 |
| 90 | MP0003763_abnormal_thymus_physiology | 0.88170697 |
| 91 | MP0002098_abnormal_vibrissa_morphology | 0.87869630 |
| 92 | MP0003252_abnormal_bile_duct | 0.86125030 |
| 93 | MP0005623_abnormal_meninges_morphology | 0.85104333 |
| 94 | MP0002060_abnormal_skin_morphology | 0.82509790 |
| 95 | MP0000767_abnormal_smooth_muscle | 0.82384902 |
| 96 | MP0009115_abnormal_fat_cell | 0.82296911 |
| 97 | MP0001873_stomach_inflammation | 0.82055289 |
| 98 | MP0001819_abnormal_immune_cell | 0.82036169 |
| 99 | MP0010630_abnormal_cardiac_muscle | 0.81818806 |
| 100 | MP0002075_abnormal_coat/hair_pigmentati | 0.81575824 |
| 101 | MP0002420_abnormal_adaptive_immunity | 0.81107712 |
| 102 | MP0000579_abnormal_nail_morphology | 0.81072361 |
| 103 | MP0005360_urolithiasis | 0.79265383 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.78634428 |
| 105 | MP0002249_abnormal_larynx_morphology | 0.78235633 |
| 106 | MP0003279_aneurysm | 0.77733116 |
| 107 | MP0002405_respiratory_system_inflammati | 0.75444462 |
| 108 | MP0001502_abnormal_circadian_rhythm | 0.74997335 |
| 109 | MP0003633_abnormal_nervous_system | 0.74884870 |
| 110 | MP0005166_decreased_susceptibility_to | 0.74451907 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.74170318 |
| 112 | MP0003448_altered_tumor_morphology | 0.73465366 |
| 113 | MP0005310_abnormal_salivary_gland | 0.73332746 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.72286500 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.71942748 |
| 116 | MP0000685_abnormal_immune_system | 0.71313159 |
| 117 | MP0000249_abnormal_blood_vessel | 0.70915456 |
| 118 | MP0003634_abnormal_glial_cell | 0.70165188 |
| 119 | MP0003890_abnormal_embryonic-extraembry | 0.69523136 |
| 120 | MP0005387_immune_system_phenotype | 0.69359385 |
| 121 | MP0001790_abnormal_immune_system | 0.69359385 |
| 122 | MP0009785_altered_susceptibility_to | 0.69042970 |
| 123 | MP0002118_abnormal_lipid_homeostasis | 0.67697079 |
| 124 | MP0000609_abnormal_liver_physiology | 0.67390163 |
| 125 | MP0002006_tumorigenesis | 0.66750392 |
| 126 | MP0003828_pulmonary_edema | 0.66460165 |
| 127 | MP0002139_abnormal_hepatobiliary_system | 0.65988379 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.64645585 |
| 129 | MP0005167_abnormal_blood-brain_barrier | 0.64233757 |
| 130 | MP0002971_abnormal_brown_adipose | 0.63888091 |
| 131 | MP0001849_ear_inflammation | 0.63590642 |
| 132 | MP0010386_abnormal_urinary_bladder | 0.62997706 |
| 133 | MP0004087_abnormal_muscle_fiber | 0.61667371 |
| 134 | MP0000733_abnormal_muscle_development | 0.60680811 |
| 135 | MP0001186_pigmentation_phenotype | 0.59896648 |
| 136 | MP0000538_abnormal_urinary_bladder | 0.59706159 |
| 137 | MP0001835_abnormal_antigen_presentation | 0.59546347 |
| 138 | MP0005621_abnormal_cell_physiology | 0.57268100 |
| 139 | MP0000470_abnormal_stomach_morphology | 0.57091151 |
| 140 | MP0010329_abnormal_lipoprotein_level | 0.57049530 |
| 141 | MP0002332_abnormal_exercise_endurance | 0.56862544 |
| 142 | MP0002254_reproductive_system_inflammat | 0.56356359 |
| 143 | MP0002009_preneoplasia | 0.55353506 |
| 144 | MP0002135_abnormal_kidney_morphology | 0.55130023 |
| 145 | MP0005645_abnormal_hypothalamus_physiol | 0.55003452 |
| 146 | MP0004019_abnormal_vitamin_homeostasis | 0.54851696 |
| 147 | MP0005375_adipose_tissue_phenotype | 0.54603086 |
| 148 | MP0000003_abnormal_adipose_tissue | 0.53812616 |
| 149 | MP0005334_abnormal_fat_pad | 0.53334268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.57487185 |
| 2 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.57487185 |
| 3 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.57487185 |
| 4 | Dysostosis multiplex (HP:0000943) | 4.46363767 |
| 5 | Mucopolysacchariduria (HP:0008155) | 4.44325021 |
| 6 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.44325021 |
| 7 | Cerebral aneurysm (HP:0004944) | 4.11094878 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.01662191 |
| 9 | Turricephaly (HP:0000262) | 3.79894259 |
| 10 | Obstructive sleep apnea (HP:0002870) | 3.71744146 |
| 11 | Broad face (HP:0000283) | 3.54304263 |
| 12 | Asymmetric septal hypertrophy (HP:0001670) | 3.48952204 |
| 13 | J-shaped sella turcica (HP:0002680) | 3.43133103 |
| 14 | Alopecia of scalp (HP:0002293) | 3.27420597 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.10839409 |
| 16 | Malnutrition (HP:0004395) | 3.03447584 |
| 17 | Ulnar bowing (HP:0003031) | 3.01791624 |
| 18 | Nuclear cataract (HP:0100018) | 2.86921886 |
| 19 | Pustule (HP:0200039) | 2.86090558 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 2.80139889 |
| 21 | Hand muscle atrophy (HP:0009130) | 2.79048402 |
| 22 | Neurofibrillary tangles (HP:0002185) | 2.78386166 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76558969 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76558969 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76558969 |
| 26 | Hemorrhage of the eye (HP:0011885) | 2.71775240 |
| 27 | Distal upper limb amyotrophy (HP:0007149) | 2.68814109 |
| 28 | Upper limb amyotrophy (HP:0009129) | 2.68814109 |
| 29 | Myocardial infarction (HP:0001658) | 2.65623941 |
| 30 | Urethral obstruction (HP:0000796) | 2.62602235 |
| 31 | Increased CSF protein (HP:0002922) | 2.51401159 |
| 32 | Thoracic kyphosis (HP:0002942) | 2.47518325 |
| 33 | Flat acetabular roof (HP:0003180) | 2.46695352 |
| 34 | Albinism (HP:0001022) | 2.44272890 |
| 35 | Axonal loss (HP:0003447) | 2.39242507 |
| 36 | Macroorchidism (HP:0000053) | 2.37559416 |
| 37 | Stridor (HP:0010307) | 2.37352078 |
| 38 | Loss of speech (HP:0002371) | 2.37100716 |
| 39 | Supranuclear gaze palsy (HP:0000605) | 2.36147087 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.35194578 |
| 41 | Global brain atrophy (HP:0002283) | 2.32935496 |
| 42 | Coarse hair (HP:0002208) | 2.32849820 |
| 43 | Annular pancreas (HP:0001734) | 2.32378365 |
| 44 | Long toe (HP:0010511) | 2.29902011 |
| 45 | Colitis (HP:0002583) | 2.27767646 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.27238709 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.25365674 |
| 48 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.12883450 |
| 49 | Heterotopia (HP:0002282) | 2.07385362 |
| 50 | Aneurysm (HP:0002617) | 2.06082128 |
| 51 | Increased connective tissue (HP:0009025) | 2.04809803 |
| 52 | Abnormality of macrophages (HP:0004311) | 2.03480252 |
| 53 | Neuronal loss in central nervous system (HP:0002529) | 2.03233956 |
| 54 | Abnormality of the periventricular white matter (HP:0002518) | 2.00943286 |
| 55 | Progressive hearing impairment (HP:0001730) | 2.00689867 |
| 56 | Distal lower limb amyotrophy (HP:0008944) | 2.00298338 |
| 57 | Progressive sensorineural hearing impairment (HP:0000408) | 1.99431347 |
| 58 | Deformed sella turcica (HP:0002681) | 1.99252668 |
| 59 | Generalized hypopigmentation (HP:0007513) | 1.98277428 |
| 60 | Atrophic scars (HP:0001075) | 1.97397674 |
| 61 | Frequent falls (HP:0002359) | 1.97356417 |
| 62 | Pathologic fracture (HP:0002756) | 1.97244176 |
| 63 | Joint stiffness (HP:0001387) | 1.97221072 |
| 64 | Bronchomalacia (HP:0002780) | 1.96330046 |
| 65 | Difficulty climbing stairs (HP:0003551) | 1.95375282 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 1.94009507 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 1.91827778 |
| 68 | Ocular albinism (HP:0001107) | 1.91738315 |
| 69 | Cervical subluxation (HP:0003308) | 1.91665522 |
| 70 | Easy fatigability (HP:0003388) | 1.91464586 |
| 71 | Gingivitis (HP:0000230) | 1.90808481 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89806937 |
| 73 | Abnormality of vision evoked potentials (HP:0000649) | 1.88790363 |
| 74 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.87469227 |
| 75 | Onion bulb formation (HP:0003383) | 1.86615438 |
| 76 | Emphysema (HP:0002097) | 1.85687106 |
| 77 | Spinal muscular atrophy (HP:0007269) | 1.83670414 |
| 78 | Intestinal fistula (HP:0100819) | 1.83568150 |
| 79 | Hypoplastic ischia (HP:0003175) | 1.82166843 |
| 80 | Increased IgE level (HP:0003212) | 1.81778953 |
| 81 | Hyperacusis (HP:0010780) | 1.80170528 |
| 82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.78285099 |
| 83 | Periodontitis (HP:0000704) | 1.77704966 |
| 84 | Abnormality of the fingertips (HP:0001211) | 1.77434126 |
| 85 | Thin bony cortex (HP:0002753) | 1.75824332 |
| 86 | Peripheral demyelination (HP:0011096) | 1.74260830 |
| 87 | Fragile skin (HP:0001030) | 1.74245037 |
| 88 | Bowed forearm bones (HP:0003956) | 1.74238315 |
| 89 | Bowing of the arm (HP:0006488) | 1.74238315 |
| 90 | Bone pain (HP:0002653) | 1.73760008 |
| 91 | Retinal atrophy (HP:0001105) | 1.73705730 |
| 92 | Hypercortisolism (HP:0001578) | 1.73005633 |
| 93 | Lymphangioma (HP:0100764) | 1.72306662 |
| 94 | Milia (HP:0001056) | 1.72121518 |
| 95 | Tetany (HP:0001281) | 1.71019054 |
| 96 | Eczematoid dermatitis (HP:0000976) | 1.70605651 |
| 97 | Natal tooth (HP:0000695) | 1.69950048 |
| 98 | Large for gestational age (HP:0001520) | 1.69455602 |
| 99 | Lower limb amyotrophy (HP:0007210) | 1.69375287 |
| 100 | Abdominal distention (HP:0003270) | 1.68853561 |
| 101 | Tetraparesis (HP:0002273) | 1.67448343 |
| 102 | Abnormality of the nasal mucosa (HP:0000433) | 1.66905952 |
| 103 | Absent frontal sinuses (HP:0002688) | 1.66033266 |
| 104 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.64325895 |
| 105 | Protuberant abdomen (HP:0001538) | 1.63845955 |
| 106 | Clumsiness (HP:0002312) | 1.63817491 |
| 107 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.63308973 |
| 108 | Abnormality of the ischium (HP:0003174) | 1.62953439 |
| 109 | Apathy (HP:0000741) | 1.62748274 |
| 110 | Inflammation of the large intestine (HP:0002037) | 1.61513729 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.60625558 |
| 112 | Long palpebral fissure (HP:0000637) | 1.59961394 |
| 113 | Hemiplegia (HP:0002301) | 1.59865022 |
| 114 | Polygenic inheritance (HP:0010982) | 1.59848866 |
| 115 | Increased serum ferritin (HP:0003281) | 1.58952079 |
| 116 | Ankle clonus (HP:0011448) | 1.58714788 |
| 117 | Abnormality of proline metabolism (HP:0010907) | 1.58380674 |
| 118 | Hydroxyprolinuria (HP:0003080) | 1.58380674 |
| 119 | Distal lower limb muscle weakness (HP:0009053) | 1.58124130 |
| 120 | Congenital hip dislocation (HP:0001374) | 1.57978016 |
| 121 | Male infertility (HP:0003251) | 1.56321049 |
| 122 | Ovoid vertebral bodies (HP:0003300) | 1.55773450 |
| 123 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.55631858 |
| 124 | Premature loss of primary teeth (HP:0006323) | 1.55223007 |
| 125 | Rapidly progressive (HP:0003678) | 1.55053313 |
| 126 | Pointed chin (HP:0000307) | 1.54550864 |
| 127 | Flattened epiphyses (HP:0003071) | 1.54276723 |
| 128 | Advanced eruption of teeth (HP:0006288) | 1.54242532 |
| 129 | Status epilepticus (HP:0002133) | 1.54156278 |
| 130 | Spondylolisthesis (HP:0003302) | 1.53983566 |
| 131 | Short nail (HP:0001799) | 1.53559526 |
| 132 | Shallow orbits (HP:0000586) | 1.52762127 |
| 133 | Diminished motivation (HP:0000745) | 1.52260369 |
| 134 | Hypertriglyceridemia (HP:0002155) | 1.52170083 |
| 135 | Systemic lupus erythematosus (HP:0002725) | 1.51859809 |
| 136 | Upper motor neuron abnormality (HP:0002127) | 1.51569412 |
| 137 | EMG: neuropathic changes (HP:0003445) | 1.51557872 |
| 138 | Leiomyosarcoma (HP:0100243) | 1.51354502 |
| 139 | Uterine leiomyosarcoma (HP:0002891) | 1.51354502 |
| 140 | Glomerulonephritis (HP:0000099) | 1.51176114 |
| 141 | Hypoplasia of the odontoid process (HP:0003311) | 1.51046400 |
| 142 | Hypophosphatemia (HP:0002148) | 1.50781830 |
| 143 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.50778465 |
| 144 | Nephritis (HP:0000123) | 1.50656990 |
| 145 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.50425742 |
| 146 | Gastrointestinal inflammation (HP:0004386) | 1.50368436 |
| 147 | Aortic regurgitation (HP:0001659) | 1.50216442 |
| 148 | Thick nail (HP:0001805) | 1.49769949 |
| 149 | Achilles tendon contracture (HP:0001771) | 1.49145555 |
| 150 | Iris hypopigmentation (HP:0007730) | 1.49074487 |
| 151 | Abnormality of the thoracic spine (HP:0100711) | 1.48467781 |
| 152 | Abnormality of the astrocytes (HP:0100707) | 1.48037741 |
| 153 | Abnormality of the sella turcica (HP:0002679) | 1.46600962 |
| 154 | Abnormality of the odontoid process (HP:0003310) | 1.46320233 |
| 155 | Dysmetric saccades (HP:0000641) | 1.46043308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 3.71752909 |
| 2 | MST1R | 2.74410533 |
| 3 | DDR2 | 2.73331520 |
| 4 | TRIB3 | 2.52467747 |
| 5 | ERN1 | 2.45564837 |
| 6 | SIK2 | 2.43013050 |
| 7 | TAOK3 | 2.36156147 |
| 8 | MAPK15 | 2.12046739 |
| 9 | CAMK1D | 2.03996668 |
| 10 | RIPK1 | 2.00310122 |
| 11 | CAMK1G | 2.00009423 |
| 12 | PDGFRA | 1.93850562 |
| 13 | TTN | 1.90321830 |
| 14 | CDK12 | 1.86969688 |
| 15 | BMX | 1.82955411 |
| 16 | SIK1 | 1.71401512 |
| 17 | MAP3K6 | 1.69315367 |
| 18 | PKN2 | 1.69211245 |
| 19 | EEF2K | 1.65861565 |
| 20 | STK38 | 1.54296371 |
| 21 | PTK6 | 1.53915011 |
| 22 | FGR | 1.51612812 |
| 23 | BLK | 1.48960924 |
| 24 | SMG1 | 1.47427035 |
| 25 | MATK | 1.44457773 |
| 26 | RIPK4 | 1.41252084 |
| 27 | CDC42BPA | 1.38646668 |
| 28 | PTK2 | 1.36362402 |
| 29 | PRPF4B | 1.35674699 |
| 30 | CSK | 1.32567281 |
| 31 | DYRK1B | 1.31305494 |
| 32 | TYRO3 | 1.25172268 |
| 33 | LATS1 | 1.25084163 |
| 34 | DAPK2 | 1.22136573 |
| 35 | PRKD2 | 1.20249379 |
| 36 | MTOR | 1.20235418 |
| 37 | MAP3K9 | 1.18950028 |
| 38 | SIK3 | 1.17528487 |
| 39 | DAPK1 | 1.17100388 |
| 40 | MAP3K10 | 1.15960375 |
| 41 | PINK1 | 1.11305912 |
| 42 | CDK6 | 1.11112962 |
| 43 | JAK1 | 1.10381174 |
| 44 | TRPM7 | 1.09268763 |
| 45 | MAP2K6 | 1.05619360 |
| 46 | PRKD3 | 1.04472222 |
| 47 | MET | 1.03008451 |
| 48 | MAP3K13 | 1.02350040 |
| 49 | TYK2 | 1.01298739 |
| 50 | KIT | 0.99581632 |
| 51 | MAPKAPK3 | 0.98855401 |
| 52 | CAMKK1 | 0.98701287 |
| 53 | SGK3 | 0.98632438 |
| 54 | MAP3K11 | 0.98307508 |
| 55 | MAP3K7 | 0.96364763 |
| 56 | INSRR | 0.94262534 |
| 57 | NME2 | 0.94017155 |
| 58 | LMTK2 | 0.93226272 |
| 59 | SCYL2 | 0.93012033 |
| 60 | PDGFRB | 0.89704376 |
| 61 | TESK1 | 0.87045269 |
| 62 | MAP3K1 | 0.86807474 |
| 63 | HIPK2 | 0.85775030 |
| 64 | RPS6KL1 | 0.84970264 |
| 65 | RPS6KC1 | 0.84970264 |
| 66 | TBK1 | 0.83442816 |
| 67 | IRAK3 | 0.80956634 |
| 68 | MAPK12 | 0.79656731 |
| 69 | PRKAA1 | 0.76842393 |
| 70 | RPS6KA6 | 0.76192505 |
| 71 | GRK6 | 0.74167280 |
| 72 | EPHA2 | 0.73146287 |
| 73 | MAP3K14 | 0.70549060 |
| 74 | JAK2 | 0.68815057 |
| 75 | CHUK | 0.67695845 |
| 76 | PAK6 | 0.67416711 |
| 77 | EPHB1 | 0.66899146 |
| 78 | MAP4K1 | 0.66121779 |
| 79 | WNK1 | 0.66098925 |
| 80 | PRKCH | 0.65032730 |
| 81 | HCK | 0.64167687 |
| 82 | MARK2 | 0.63944498 |
| 83 | TGFBR2 | 0.62836856 |
| 84 | JAK3 | 0.62718618 |
| 85 | NTRK1 | 0.62236253 |
| 86 | YES1 | 0.61865809 |
| 87 | PAK4 | 0.60819895 |
| 88 | UHMK1 | 0.60739507 |
| 89 | EGFR | 0.60254322 |
| 90 | TAOK2 | 0.59482518 |
| 91 | ZAP70 | 0.58832277 |
| 92 | IRAK2 | 0.58628725 |
| 93 | SGK1 | 0.57779851 |
| 94 | CSF1R | 0.56246214 |
| 95 | RPS6KA2 | 0.54880553 |
| 96 | TNK2 | 0.54868190 |
| 97 | PDPK1 | 0.54188006 |
| 98 | SGK2 | 0.53964468 |
| 99 | GSK3A | 0.53951875 |
| 100 | PIM1 | 0.53722544 |
| 101 | IRAK4 | 0.52507542 |
| 102 | MAPK7 | 0.52461073 |
| 103 | IKBKE | 0.51632204 |
| 104 | BRD4 | 0.51200568 |
| 105 | MAP2K3 | 0.51066883 |
| 106 | STK3 | 0.50443844 |
| 107 | BTK | 0.50410843 |
| 108 | MUSK | 0.49590511 |
| 109 | IKBKB | 0.49238953 |
| 110 | FES | 0.49236612 |
| 111 | LATS2 | 0.49084976 |
| 112 | ERBB2 | 0.48820535 |
| 113 | ALK | 0.48662618 |
| 114 | FLT3 | 0.48545675 |
| 115 | PRKAA2 | 0.47919394 |
| 116 | MAP3K3 | 0.46558813 |
| 117 | DMPK | 0.46300671 |
| 118 | PRKG2 | 0.46145074 |
| 119 | RET | 0.45992130 |
| 120 | FGFR4 | 0.45056691 |
| 121 | MARK3 | 0.44794156 |
| 122 | MAPK11 | 0.44726603 |
| 123 | PDK1 | 0.43541258 |
| 124 | MAP2K2 | 0.43449763 |
| 125 | TAOK1 | 0.43150645 |
| 126 | CAMK4 | 0.43001245 |
| 127 | PRKD1 | 0.41144432 |
| 128 | KSR2 | 0.40555406 |
| 129 | PIM2 | 0.39502438 |
| 130 | MAPK8 | 0.37937691 |
| 131 | ARAF | 0.37432310 |
| 132 | MAP3K2 | 0.36572152 |
| 133 | NTRK3 | 0.36055710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.82156246 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 2.41375162 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.86700412 |
| 4 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.84264826 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77520099 |
| 6 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.75248183 |
| 7 | Lysine degradation_Homo sapiens_hsa00310 | 1.73758341 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.63094363 |
| 9 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.49365408 |
| 10 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.34015042 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25677579 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.25594017 |
| 13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23200462 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22503930 |
| 15 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19198793 |
| 16 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.17326988 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14093056 |
| 18 | Insulin resistance_Homo sapiens_hsa04931 | 1.13923033 |
| 19 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.10668197 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09116149 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08494730 |
| 22 | Hepatitis C_Homo sapiens_hsa05160 | 1.05524403 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.05446046 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03674592 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.03575199 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.02116458 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.01120563 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00389832 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98215557 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97524139 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97179191 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 0.95913963 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95590966 |
| 34 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94912608 |
| 35 | Adherens junction_Homo sapiens_hsa04520 | 0.93230005 |
| 36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.91947633 |
| 37 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.91775496 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 0.91181718 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90067198 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89034507 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88934142 |
| 42 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.88274840 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.86492861 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86086041 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85399847 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.84918735 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.84895046 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.84771830 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84279291 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83990722 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83971935 |
| 52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83863936 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.83346193 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 0.80632201 |
| 55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80286751 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79997455 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.79427741 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79309914 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.78965510 |
| 60 | Long-term potentiation_Homo sapiens_hsa04720 | 0.78874591 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78752554 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.78508395 |
| 63 | Leishmaniasis_Homo sapiens_hsa05140 | 0.78368775 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78107490 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.77421104 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76632053 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.76199010 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76164888 |
| 69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75019402 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74227594 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74219611 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74014983 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72304269 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71308258 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71166434 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71090549 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70914044 |
| 78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.70499290 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70336586 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70294469 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69511189 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69312609 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68433823 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67839241 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.67631339 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67040965 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66660441 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.66042651 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.64836902 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64375279 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64320652 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64313776 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.64002712 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63693191 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63618226 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63180190 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62203518 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61198349 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61098747 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.60653782 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60396753 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59962126 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59079290 |
| 104 | Malaria_Homo sapiens_hsa05144 | 0.58957019 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58835178 |
| 106 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58220882 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57414964 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57329416 |
| 109 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57235285 |
| 110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57033205 |
| 111 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56977061 |
| 112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54956069 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54479190 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53664700 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53235577 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53068509 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.51826726 |
| 118 | Influenza A_Homo sapiens_hsa05164 | 0.51739466 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.50576414 |
| 120 | Salivary secretion_Homo sapiens_hsa04970 | 0.50406001 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50328036 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49826655 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49376381 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49284081 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.49274595 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48277948 |
| 127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47827124 |

